Bari, Notte ricercatori e IRCCS con Antonella Viola
Investire maggiormente nella ricerca e stimolare gli studenti. In Fiera del Levante appendice con l’Istituto...
L'articolo Bari, Notte ricercatori e IRCCS con Antonella Viola proviene da Antenna Sud.
www.antennasud.com
September 27, 2026 at 7:57 AM
$BNGO - Bionano
19-Nov-2024
"Small Complex Rearrangement in HINT1-Related Axonal Neuropathy"
Italian scientists from the University of Pisa, the IRCCS Stella Maris Foundation, Pisa, and the IRCCS Eugenio Medea, Bosisio Parini, Italy, publish the above study.
1/5
19-Nov-2024
"Small Complex Rearrangement in HINT1-Related Axonal Neuropathy"
Italian scientists from the University of Pisa, the IRCCS Stella Maris Foundation, Pisa, and the IRCCS Eugenio Medea, Bosisio Parini, Italy, publish the above study.
1/5
November 20, 2024 at 2:25 AM
$BNGO - Bionano
19-Nov-2024
"Small Complex Rearrangement in HINT1-Related Axonal Neuropathy"
Italian scientists from the University of Pisa, the IRCCS Stella Maris Foundation, Pisa, and the IRCCS Eugenio Medea, Bosisio Parini, Italy, publish the above study.
1/5
19-Nov-2024
"Small Complex Rearrangement in HINT1-Related Axonal Neuropathy"
Italian scientists from the University of Pisa, the IRCCS Stella Maris Foundation, Pisa, and the IRCCS Eugenio Medea, Bosisio Parini, Italy, publish the above study.
1/5
Prof Paolo Ascierto #Melanoma #Immunotherapy ROCKSTAR Istituto Nazionale IRCCS Fondazione “G Pascale” talks about salvage therapy post 1st line failure #Bridge2024 @sitcancer.bsky.social @PAscierto
December 7, 2024 at 3:52 PM
Prof Paolo Ascierto #Melanoma #Immunotherapy ROCKSTAR Istituto Nazionale IRCCS Fondazione “G Pascale” talks about salvage therapy post 1st line failure #Bridge2024 @sitcancer.bsky.social @PAscierto
Epigenetics Preprint - Cell cycle control of chromatin creates a therapeutic window for epigenetic therapy in tumors u.epigenome.us/tDyhFaBS
Kourosh Hayatigolkhatmi and Saverio Minucci (IRCCS) in biorxivpreprint.bsky.social
#Epigenetics #Preprint #Chromatin
---
epigenometech.com
Kourosh Hayatigolkhatmi and Saverio Minucci (IRCCS) in biorxivpreprint.bsky.social
#Epigenetics #Preprint #Chromatin
---
epigenometech.com
September 10, 2026 at 11:34 AM
Epigenetics Preprint - Cell cycle control of chromatin creates a therapeutic window for epigenetic therapy in tumors u.epigenome.us/tDyhFaBS
Kourosh Hayatigolkhatmi and Saverio Minucci (IRCCS) in biorxivpreprint.bsky.social
#Epigenetics #Preprint #Chromatin
---
epigenometech.com
Kourosh Hayatigolkhatmi and Saverio Minucci (IRCCS) in biorxivpreprint.bsky.social
#Epigenetics #Preprint #Chromatin
---
epigenometech.com
Exciting times ahead!
@ERC_Research
@ArmeniseHarvard
#ERCCoG
@MyUniSR
@SanRaffaeleMI
🔗 Found out more here: www.unisr.it/en/news/2024...
www.unisr.it/en/news/2024...
Stay tuned—opportunities to join our team are coming soon!
@ERC_Research
@ArmeniseHarvard
#ERCCoG
@MyUniSR
@SanRaffaeleMI
🔗 Found out more here: www.unisr.it/en/news/2024...
www.unisr.it/en/news/2024...
Stay tuned—opportunities to join our team are coming soon!
San Raffaele wins three ERC Consolidator Grants 2024
European Research Council (ERC) has announced the winners of the Consolidator Grant 2024: among them 3 researchers from UniSR and IRCCS Ospedale San Raffaele
www.unisr.it
December 3, 2024 at 12:53 PM
Exciting times ahead!
@ERC_Research
@ArmeniseHarvard
#ERCCoG
@MyUniSR
@SanRaffaeleMI
🔗 Found out more here: www.unisr.it/en/news/2024...
www.unisr.it/en/news/2024...
Stay tuned—opportunities to join our team are coming soon!
@ERC_Research
@ArmeniseHarvard
#ERCCoG
@MyUniSR
@SanRaffaeleMI
🔗 Found out more here: www.unisr.it/en/news/2024...
www.unisr.it/en/news/2024...
Stay tuned—opportunities to join our team are coming soon!
📣 Don’t miss the review by @bolettalab.bsky.social & S. Clerici on metabolic and mitochondrial alterations in #PolycysticKidneyDisease and other renal #ciliopathies ➡️ doi.org/10.1038/s443...
at IRCCS San Raffaele Scientific Institute
at IRCCS San Raffaele Scientific Institute
April 22, 2025 at 2:49 PM
📣 Don’t miss the review by @bolettalab.bsky.social & S. Clerici on metabolic and mitochondrial alterations in #PolycysticKidneyDisease and other renal #ciliopathies ➡️ doi.org/10.1038/s443...
at IRCCS San Raffaele Scientific Institute
at IRCCS San Raffaele Scientific Institute
A few days ago, @eugenioparise.bsky.social was at Medea BabyLab (IRCCS Medea, LC, Italy) to lead a hands-on tutorial on infant EEG analysis using our #WTools toolbox.
A great opportunity to share expertise and connect with researchers studying brain development in the first years of life! 🧠👶
A great opportunity to share expertise and connect with researchers studying brain development in the first years of life! 🧠👶
October 20, 2025 at 12:10 PM
A few days ago, @eugenioparise.bsky.social was at Medea BabyLab (IRCCS Medea, LC, Italy) to lead a hands-on tutorial on infant EEG analysis using our #WTools toolbox.
A great opportunity to share expertise and connect with researchers studying brain development in the first years of life! 🧠👶
A great opportunity to share expertise and connect with researchers studying brain development in the first years of life! 🧠👶
#ImageOfTheWeek by Andrea Provera, Ginevra Annoni and Edoardo Conte from IRCCS Galeazzi Sant'Ambrogio in Milan, Italy.
What is the imaging finding for this 57-year-old male with increased interventricular septal thickness? bit.ly/3WMHUVE
#cardioed #ESCYoung
What is the imaging finding for this 57-year-old male with increased interventricular septal thickness? bit.ly/3WMHUVE
#cardioed #ESCYoung
February 6, 2025 at 1:32 PM
#ImageOfTheWeek by Andrea Provera, Ginevra Annoni and Edoardo Conte from IRCCS Galeazzi Sant'Ambrogio in Milan, Italy.
What is the imaging finding for this 57-year-old male with increased interventricular septal thickness? bit.ly/3WMHUVE
#cardioed #ESCYoung
What is the imaging finding for this 57-year-old male with increased interventricular septal thickness? bit.ly/3WMHUVE
#cardioed #ESCYoung
📢Publication Alert🌶️! #IRCCS developed a #multiomics workflow for #lipidomics and EV #proteomics analysis of very preterm infants using just 10 µl of plasma with #Mag_Net (from the lab of @maccoss.bsky.social) #TeamMassSpec #TeamReSynBio www.medrxiv.org/content/10.6...
March 9, 2026 at 10:22 AM
📢Publication Alert🌶️! #IRCCS developed a #multiomics workflow for #lipidomics and EV #proteomics analysis of very preterm infants using just 10 µl of plasma with #Mag_Net (from the lab of @maccoss.bsky.social) #TeamMassSpec #TeamReSynBio www.medrxiv.org/content/10.6...
We’re honoured to collaborate with Fondazione IRCCS Ca’ Granda – Ospedale Maggiore Policlinico 🇮🇹 in the GENIAL Project!
🔗 Learn more: www.policlinico.mi.it
🔗Discover GENIAL: genial-project.com
#HorizonEurope #AI #CancerResearch
🔗 Learn more: www.policlinico.mi.it
🔗Discover GENIAL: genial-project.com
#HorizonEurope #AI #CancerResearch
September 2, 2025 at 7:30 AM
We’re honoured to collaborate with Fondazione IRCCS Ca’ Granda – Ospedale Maggiore Policlinico 🇮🇹 in the GENIAL Project!
🔗 Learn more: www.policlinico.mi.it
🔗Discover GENIAL: genial-project.com
#HorizonEurope #AI #CancerResearch
🔗 Learn more: www.policlinico.mi.it
🔗Discover GENIAL: genial-project.com
#HorizonEurope #AI #CancerResearch
🧪🧠 Rovereto CuttingEEG Garden 2026 – REGISTRATIONS OPEN
We're thrilled to announce that @cimecunitrento.bsky.social and DIPSCO (UniTrento), in collaboration with Università degli Studi Milano-Bicocca and IRCCS Eugenio Medea, will host the Rovereto @cuttingeeg.bsky.social Garden
📅 21–25 Sept 2026
We're thrilled to announce that @cimecunitrento.bsky.social and DIPSCO (UniTrento), in collaboration with Università degli Studi Milano-Bicocca and IRCCS Eugenio Medea, will host the Rovereto @cuttingeeg.bsky.social Garden
📅 21–25 Sept 2026
August 3, 2026 at 8:23 AM
🧪🧠 Rovereto CuttingEEG Garden 2026 – REGISTRATIONS OPEN
We're thrilled to announce that @cimecunitrento.bsky.social and DIPSCO (UniTrento), in collaboration with Università degli Studi Milano-Bicocca and IRCCS Eugenio Medea, will host the Rovereto @cuttingeeg.bsky.social Garden
📅 21–25 Sept 2026
We're thrilled to announce that @cimecunitrento.bsky.social and DIPSCO (UniTrento), in collaboration with Università degli Studi Milano-Bicocca and IRCCS Eugenio Medea, will host the Rovereto @cuttingeeg.bsky.social Garden
📅 21–25 Sept 2026
Colon cancer can be considered cured after 6 years when relapse risk falls below 0.5%. In a new study published in JAMA Oncology, researchers pooled data from multiple studies to determine when relapse risk becomes negligible👇
Colon cancer considered cured after six years when relapse risk falls below 0.5%
IRCCS Ospedale Policlinico San Martino with Mayo Clinic and multiple international cancer research centers have delivered a pooled analysis indicating that colon cancer recurrence risk drops below 0.5...
medicalxpress.com
October 7, 2025 at 11:44 AM
Colon cancer can be considered cured after 6 years when relapse risk falls below 0.5%. In a new study published in JAMA Oncology, researchers pooled data from multiple studies to determine when relapse risk becomes negligible👇
Huge thanks to colleagues at the Wellcome Sanger Institute, and to collaborators at GSK, IDEAYA, the Candiolo Cancer Institute IRCCS, the Babraham Institute, and all partners who make this work possible. @mgarnett.bsky.social @mattcoelho.bsky.social @houseleylab.bsky.social @emanuelvgo.bsky.social
December 28, 2025 at 7:12 AM
Huge thanks to colleagues at the Wellcome Sanger Institute, and to collaborators at GSK, IDEAYA, the Candiolo Cancer Institute IRCCS, the Babraham Institute, and all partners who make this work possible. @mgarnett.bsky.social @mattcoelho.bsky.social @houseleylab.bsky.social @emanuelvgo.bsky.social
Fondazione IRCCS Ca’ Granda, 48 people with Long COVID.
Four weeks of VSL#3 (high dose probiotic) reduced fatigue more than placebo, with 68% responding versus 35.7%.
Responders also showed shifts in gut bacteria and immune signaling.
www.frontierspartnerships.org/journals/bri...
Four weeks of VSL#3 (high dose probiotic) reduced fatigue more than placebo, with 68% responding versus 35.7%.
Responders also showed shifts in gut bacteria and immune signaling.
www.frontierspartnerships.org/journals/bri...
Frontiers Publishing Partnerships | VSL#3® supplementation improves fatigue in long COVID: results from the DELong#3 randomized placebo-controlled trial
BackgroundLong COVID is frequently characterized by persistent fatigue and impaired quality of life. Increasing evidence suggests that gut microbiota dysbios...
www.frontierspartnerships.org
August 11, 2026 at 9:58 PM
Fondazione IRCCS Ca’ Granda, 48 people with Long COVID.
Four weeks of VSL#3 (high dose probiotic) reduced fatigue more than placebo, with 68% responding versus 35.7%.
Responders also showed shifts in gut bacteria and immune signaling.
www.frontierspartnerships.org/journals/bri...
Four weeks of VSL#3 (high dose probiotic) reduced fatigue more than placebo, with 68% responding versus 35.7%.
Responders also showed shifts in gut bacteria and immune signaling.
www.frontierspartnerships.org/journals/bri...
Honored to give a #CognitivePupillometry workshop at #IRCCS Medea, La Nostra Famiglia, between #OpenScience, #Psychometrics, #Statistics and #Clinical practice.
🙏Chiara Cantiani & Valentina Riva for the invitation
❤️#Interdisciplinarity can turn #Research into #Care
🙏Chiara Cantiani & Valentina Riva for the invitation
❤️#Interdisciplinarity can turn #Research into #Care
October 13, 2025 at 7:52 AM
Honored to give a #CognitivePupillometry workshop at #IRCCS Medea, La Nostra Famiglia, between #OpenScience, #Psychometrics, #Statistics and #Clinical practice.
🙏Chiara Cantiani & Valentina Riva for the invitation
❤️#Interdisciplinarity can turn #Research into #Care
🙏Chiara Cantiani & Valentina Riva for the invitation
❤️#Interdisciplinarity can turn #Research into #Care
TTC7A deficiency: A retrospective international study on treatment and outcomes from the Inborn Errors Working Party of EBMT. From Giulia Prunotto, Giovanna Lucchini (IRCCS San Gerardo dei Tintori) and colleagues:
rupress.org/jhi/article/...
@theebmt.bsky.social
#InbornErrorsOfImmunity
rupress.org/jhi/article/...
@theebmt.bsky.social
#InbornErrorsOfImmunity
July 15, 2026 at 3:45 PM
TTC7A deficiency: A retrospective international study on treatment and outcomes from the Inborn Errors Working Party of EBMT. From Giulia Prunotto, Giovanna Lucchini (IRCCS San Gerardo dei Tintori) and colleagues:
rupress.org/jhi/article/...
@theebmt.bsky.social
#InbornErrorsOfImmunity
rupress.org/jhi/article/...
@theebmt.bsky.social
#InbornErrorsOfImmunity
Hi all!
We are the Group of Microbial Ecology, at IRCCS Humanitas in Milan, Italy.
To understand how microbial cells grow and interact in communities, we develop theoretical models and test them with microfluidics.
We are always on the lookout for multidisciplinary people (MSc, PhD, Postdoc)!
We are the Group of Microbial Ecology, at IRCCS Humanitas in Milan, Italy.
To understand how microbial cells grow and interact in communities, we develop theoretical models and test them with microfluidics.
We are always on the lookout for multidisciplinary people (MSc, PhD, Postdoc)!
August 13, 2024 at 8:24 AM
Hi all!
We are the Group of Microbial Ecology, at IRCCS Humanitas in Milan, Italy.
To understand how microbial cells grow and interact in communities, we develop theoretical models and test them with microfluidics.
We are always on the lookout for multidisciplinary people (MSc, PhD, Postdoc)!
We are the Group of Microbial Ecology, at IRCCS Humanitas in Milan, Italy.
To understand how microbial cells grow and interact in communities, we develop theoretical models and test them with microfluidics.
We are always on the lookout for multidisciplinary people (MSc, PhD, Postdoc)!
Italian Doctors Warn That Pfizer’s COVID-19 Vaccines Can Cause Onset of Familial Hemophagocytic Lymphohistiocytosis
www.thailandmedical.news/news/italian...
www.thailandmedical.news/news/italian...
Italian Doctors Warn That Pfizer’s COVID-19 Vaccines Can Cause Onset of Familial Hemophagocytic Lymphohistiocytosis - Thailand Medical News
Medical News: A Rare Neurological Case That Surprised Doctors
Researchers from Fondazione Policlinico Universitario A Gemelli IRCCS in Rome, IRCCS Ospedale Pediatrico Bambino Gesù, and Università Cattolica del Sacro Cuore have documented a striking adult case of familial hemophagocytic lymphohistiocytosis (HLH) that began with neurological symptoms soon after a Pfizer COVID19 vaccin...
www.thailandmedical.news
November 26, 2025 at 11:39 AM
Italian Doctors Warn That Pfizer’s COVID-19 Vaccines Can Cause Onset of Familial Hemophagocytic Lymphohistiocytosis
www.thailandmedical.news/news/italian...
www.thailandmedical.news/news/italian...
New online @lancetrh-europe.bsky.social: a personal view of lessons learned during the first year of using the anti-amyloid therapies lecanemab and donanemab at the IRCCS San Raffaele Center for Alzheimer's and Related Diseases in Milan, Italy: www.thelancet.com/journals/lan...
Anti-amyloid therapies and the transformation of Alzheimer's care pathways: early lessons from the frontline
The introduction of anti-amyloid monoclonal antibodies marks a major shift in Alzheimer's
disease (AD) care, moving treatment toward biological modification and reshaping diagnostic
and organizational...
www.thelancet.com
February 16, 2026 at 9:19 AM
New online @lancetrh-europe.bsky.social: a personal view of lessons learned during the first year of using the anti-amyloid therapies lecanemab and donanemab at the IRCCS San Raffaele Center for Alzheimer's and Related Diseases in Milan, Italy: www.thelancet.com/journals/lan...
🤩 More than 60 #STEM students took part in MIND your STEM, the event we organised with Illumina, Bio4Dreams, IRCCS Ospedale Galeazzi–Sant’Ambrogio, Bracco, Federchimica Assobiotech & the University of Milan to explore the opportunities and challenges of the STEM journey for the National STEM week!
February 5, 2025 at 10:30 AM
🤩 More than 60 #STEM students took part in MIND your STEM, the event we organised with Illumina, Bio4Dreams, IRCCS Ospedale Galeazzi–Sant’Ambrogio, Bracco, Federchimica Assobiotech & the University of Milan to explore the opportunities and challenges of the STEM journey for the National STEM week!
Lazzaro Spallanzani IRCCS studied 1 man with severe Long COVID.
High-dose IVIG was followed by recovery and fewer CD8 T cell–monocyte complexes, IFNγ, endothelial inflammation and GPCR autoantibodies.
Causality is unproven.
www.thelancet.com/journals/lan...
High-dose IVIG was followed by recovery and fewer CD8 T cell–monocyte complexes, IFNγ, endothelial inflammation and GPCR autoantibodies.
Causality is unproven.
www.thelancet.com/journals/lan...
Intravenous immunoglobulin treatment for long COVID: a case report of clinical and immunological findings
A previously healthy 39-year-old man developed highly symptomatic post-COVID-19 condition
(also known as long COVID) marked by cognitive dysfunction, disabling fatigue, and
autonomic symptoms unrespon...
www.thelancet.com
September 8, 2026 at 8:42 PM
Lazzaro Spallanzani IRCCS studied 1 man with severe Long COVID.
High-dose IVIG was followed by recovery and fewer CD8 T cell–monocyte complexes, IFNγ, endothelial inflammation and GPCR autoantibodies.
Causality is unproven.
www.thelancet.com/journals/lan...
High-dose IVIG was followed by recovery and fewer CD8 T cell–monocyte complexes, IFNγ, endothelial inflammation and GPCR autoantibodies.
Causality is unproven.
www.thelancet.com/journals/lan...
Promosso dall'Italian Sarcoma Group e coordinato da Fondazione Irccs Int di Milano con la partecipazione di Cnao Pavia
Cordoma del sacro, italiano il primo studio al mondo sull'efficacia dell'adroterapia
ebx.sh
December 6, 2025 at 8:53 AM
Promosso dall'Italian Sarcoma Group e coordinato da Fondazione Irccs Int di Milano con la partecipazione di Cnao Pavia